SG Americas Securities’s Precision BioSciences DTIL Stock Holding History

SG Americas Securities’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-550	Closed	-$20K	–	3325
2022 Q4	$20K	Sell	550 -79	-13%	-$3.12K	﹤0.01%	2934
2022 Q3	$25K	Buy	629 +41	+7%	+$1.95K	﹤0.01%	3083
2022 Q2	$28K	Buy	588 +227	+63%	+$13.3K	﹤0.01%	3319
2022 Q1	$33K	Buy	+361	New	+$49K	﹤0.01%	2866
2021 Q4	–	Sell	-741	Closed	-$256K	–	3486
2021 Q3	$256K	Buy	+741	New	+$251K	﹤0.01%	3057
2021 Q2	–	Sell	-331	Closed	-$103K	–	2932
2021 Q1	$103K	Buy	+331	New	+$116K	﹤0.01%	3072
2020 Q3	–	Sell	-831	Closed	-$208K	–	2881
2020 Q2	$208K	Buy	831 +368	+79%	+$80.6K	﹤0.01%	2831
2020 Q1	$84K	Buy	+463	New	+$121K	﹤0.01%	3064
2019 Q2	–	Sell	-267	Closed	-$144K	–	3159
2019 Q1	$144K	Buy	+267	New	+$142K	﹤0.01%	2805

Other funds holding DTIL

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SG Americas Securities's DTIL Position: Q1 2023 in Review

SG Americas Securities sold out of Precision BioSciences (DTIL) in Q1 2023, closing a stake of 550 shares — an estimated $20K sold.

SG Americas Securities first reported a position in DTIL in Q1 2019 and held it in 9 quarters. The position peaked at $256K in Q3 2021. 86 funds tracked by Wall St. Rank hold DTIL as of Q1 2023.

SG Americas Securities reported no remaining Precision BioSciences position as of Q1 2023 after selling out during the quarter.
SG Americas Securities sold 550 Precision BioSciences shares in Q1 2023, an estimated $20K.
SG Americas Securities first reported a position in Precision BioSciences in Q1 2019 and held it in 9 quarters.
SG Americas Securities's Precision BioSciences position peaked at $256K in Q3 2021.
86 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2023.

Based on SG Americas Securities's 13F filing for Q1 2023, filed 28 Apr 2023.